Acalisib
Cat.No:IA2860 Solarbio
CAS:870281-34-8
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to off-white Solid
Qty:
Size:
{{cart_num}}
My Cart>
Small Molecule Compounds >
Inhibitors & Antagonists & Agonists >
PI3K/Akt/mTOR >
AcalisibCAS:870281-34-8
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to off-white Solid
Qty:
Size:
CAS | 870281-34-8 |
Name | Acalisib |
Molecular Formula | C21H16FN7O |
Molecular Weight | 401.4 |
Solubility | Soluble in DMSO ≥5mg/mL(Need ultrasonic) |
Purity | ≥98% |
Appearance | White to off-white Solid |
Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
EC | EINECS 604-604-1 |
SMILES | O=C1N(C2=CC=CC=C2)C([C@@H](NC3=C4N=CNC4=NC=N3)C)=NC5=C1C=C(F)C=C5 |
Target Point | PI3K |
Passage | PI3K/Akt/mTOR |
Background | It is a highly selective and potent p110δ inhibitor. |
Biological Activity | Acalisib is a potent and selective PI3Kδ inhibitor with an IC50 of 12.7 nM.[1-2] |
In Vitro | Acalisib(GS-9820)is more selective for PI3Kδ(IC50=12.7 nM)relative to other PI3K class I enzymes(IC50: PI3Kα,5,441 nM; PI3Kβ,3,377 nM; PI3Kγ,1,389 nM). Acalisib is also 103-fold more selective against PI3Kδ than against related kinases,such as PI3KCIIβ(IC50>10 nM),hVPS34(IC50=12.7 μM),DNA-PK(IC50=18.7 μM),and mTOR(IC50>10 nM). In fibroblasts,the PDGF receptor signals through PI3Kα and the GPCR for lysophosphatidic acid(LPA)signals through PI3Kβ. Acalisib reduces PDGF-induced pAkt by only 50% at 11,585 nM,and LPA-induced pAkt by 50% at 2,069 nM.[1] |
In Vivo | To dissect the relative contribution of PI3Kα and PI3Kδ inhibition in the reduction of obesity,obese hyperphagic ob/ob mice are treated with a selective PI3Kα inhibitor,BYL-719,or with a selective PI3Kδ inhibitor,Acalisib(GS-9820). Remarkably,BYL-719 reduces body weight after 15 days of treatment to a similar extent as CNIO-PI3Ki,whereas Acalisib has no significant effect at the same doses as BYL-719. It should be noted that 10 mg/kg of Acalisib is sufficient to reduce the growth of multiple myeloma xenografts in mice[2]. |
Cell Experiment | The effect of inhibitors on RAW264.7 cell survival is evaluated using the MTT assay. RAW264.7 cells are seeded in Falcon flat bottom 96-well plates at a density of 2.5-3×104 cells/cm2 in 100 μL of DMEM with 10% FBS and 1% antibiotic solution. After seeding,the cells are allowed to attach for 24 h then exposed to control or Acalisib(GS-9820)(100 pM to 10 μM)for 24 h. After incubation at 37°C in 5% CO2,MTT substrate is added at a final concentration of 0.5 mg/mL for 4 h. Following a 4-h incubation,100 μL of solubilization solution is added to each well to dissolve the formazan crystals and samples are analyzed after 24 h. Absorbance of the samples is assessed using a plate reader using a wavelength of 550 nm and a reference wavelength of 700 nm[1]. |
Animal Experiment | Ob/ob C57BL6J mice and Wild-type C57BL6J/Ola.Hsd mice are housed under specific pathogen free(SPF)conditions,at 22°C,and with 12 hours dark/light cycles(light cycle from 8 am to 8 pm). All mice used are males of 20 weeks of age. Mice are fed with standard chow diet(18% of fat-based caloric content). PI3K inhibitors are administered daily by oral gavage during 15 or 16 days as follows,BYL-719(5 and 10 mg/kg)and Acalisib(5 and 10 mg/kg),CNIO-PI3Ki(1 and 5 mg/kg),dissolved in PEG-300 and 10% N-methyl-2-pyrrolidone.[2] |
Kinase Experiment | Biochemical in vitro lipid kinase assays are performed. A stock solution of Acalisib(GS-9820)is prepared in DMSO at a concentration of 10 mM. Ten-point kinase inhibitory activities are measured over a concentration range(5 to 104 nM)with ATP at a concentration consistent with the Km of each of the enzymes[1]. |
Data Literature Source | [1]. Shugg RP,et al. Effects of isoform-selective phosphatidylinositol 3-kinase inhibitors on osteoclasts: actions on cytoskeletal organization,survival,and resorption. J Biol Chem. 2013 Dec 6;288(49):35346-57. [2]. Lopez-Guadamillas E,et al. PI3Kα inhibition reduces obesity in mice. Aging (Albany NY). 2016 Nov 4;8(11):2747-2753 |
Unit | Bottle |
Specification | 2mg 5mg |
是一种具有高度选择性的、有效的p110δ抑制剂。
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.